Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease. 1991

G Perry, and S L Siedlak, and P Richey, and M Kawai, and P Cras, and R N Kalaria, and P G Galloway, and J M Scardina, and B Cordell, and B D Greenberg
Division of Neuropathology, Case Western Reserve University, Cleveland, Ohio 44106.

The major intracytoplasmic lesion of Alzheimer's disease is the neurofibrillary tangle (NFT), which is primarily composed of paired helical filaments (PHFs). The mechanism responsible for the formation of PHFs, as well as their insolubility and apparent heterogeneity, is unknown. We found that basic fibroblast growth factor (bFGF) binds to heparinase-sensitive sites in NFTs. bFGF binding is due to a heparan sulfate proteoglycan (HSPG) immunocytochemically identified in NFTs. In the presence of polycations (e.g., Ca2+), HSPG will bind to free carboxyl groups in NFT proteins. HSPG binding may play a role in transforming normal soluble proteins into insoluble PHFs.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011508 Chondroitin Sulfate Proteoglycans Proteoglycans consisting of proteins linked to one or more CHONDROITIN SULFATE-containing oligosaccharide chains. Proteochondroitin Sulfates,Chondroitin Sulfate Proteoglycan,Proteochondroitin Sulfate,Proteoglycan, Chondroitin Sulfate,Proteoglycans, Chondroitin Sulfate,Sulfate Proteoglycan, Chondroitin,Sulfate Proteoglycans, Chondroitin
D006497 Heparitin Sulfate A heteropolysaccharide that is similar in structure to HEPARIN. It accumulates in individuals with MUCOPOLYSACCHARIDOSIS. Heparan Sulfate,Sulfate, Heparan,Sulfate, Heparitin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D000682 Amyloid A fibrous protein complex that consists of proteins folded into a specific cross beta-pleated sheet structure. This fibrillar structure has been found as an alternative folding pattern for a variety of functional proteins. Deposits of amyloid in the form of AMYLOID PLAQUES are associated with a variety of degenerative diseases. The amyloid structure has also been found in a number of functional proteins that are unrelated to disease. Amyloid Fibril,Amyloid Fibrils,Amyloid Substance,Fibril, Amyloid,Fibrils, Amyloid,Substance, Amyloid
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D016222 Fibroblast Growth Factor 2 A single-chain polypeptide growth factor that plays a significant role in the process of WOUND HEALING and is a potent inducer of PHYSIOLOGIC ANGIOGENESIS. Several different forms of the human protein exist ranging from 18-24 kDa in size due to the use of alternative start sites within the fgf-2 gene. It has a 55 percent amino acid residue identity to FIBROBLAST GROWTH FACTOR 1 and has potent heparin-binding activity. The growth factor is an extremely potent inducer of DNA synthesis in a variety of cell types from mesoderm and neuroectoderm lineages. It was originally named basic fibroblast growth factor based upon its chemical properties and to distinguish it from acidic fibroblast growth factor (FIBROBLAST GROWTH FACTOR 1). Basic Fibroblast Growth Factor,Fibroblast Growth Factor, Basic,HBGF-2,Cartilage-Derived Growth Factor,Class II Heparin-Binding Growth Factor,FGF-2,FGF2,Fibroblast Growth Factor-2,Heparin-Binding Growth Factor Class II,Prostate Epithelial Cell Growth Factor,Prostatropin,Cartilage Derived Growth Factor,FGF 2
D016874 Neurofibrillary Tangles Abnormal structures located in various parts of the brain and composed of dense arrays of paired helical filaments (neurofilaments and microtubules). These double helical stacks of transverse subunits are twisted into left-handed ribbon-like filaments that likely incorporate the following proteins: (1) the intermediate filaments: medium- and high-molecular-weight neurofilaments; (2) the microtubule-associated proteins map-2 and tau; (3) actin; and (4) UBIQUITINS. As one of the hallmarks of ALZHEIMER DISEASE, the neurofibrillary tangles eventually occupy the whole of the cytoplasm in certain classes of cell in the neocortex, hippocampus, brain stem, and diencephalon. The number of these tangles, as seen in post mortem histology, correlates with the degree of dementia during life. Some studies suggest that tangle antigens leak into the systemic circulation both in the course of normal aging and in cases of Alzheimer disease. Neurofibrillary Tangle,Tangle, Neurofibrillary,Tangles, Neurofibrillary

Related Publications

G Perry, and S L Siedlak, and P Richey, and M Kawai, and P Cras, and R N Kalaria, and P G Galloway, and J M Scardina, and B Cordell, and B D Greenberg
March 1998, Frontiers in bioscience : a journal and virtual library,
G Perry, and S L Siedlak, and P Richey, and M Kawai, and P Cras, and R N Kalaria, and P G Galloway, and J M Scardina, and B Cordell, and B D Greenberg
January 1987, Journal of neural transmission. Supplementum,
G Perry, and S L Siedlak, and P Richey, and M Kawai, and P Cras, and R N Kalaria, and P G Galloway, and J M Scardina, and B Cordell, and B D Greenberg
October 1998, European neurology,
G Perry, and S L Siedlak, and P Richey, and M Kawai, and P Cras, and R N Kalaria, and P G Galloway, and J M Scardina, and B Cordell, and B D Greenberg
May 2001, The American journal of pathology,
G Perry, and S L Siedlak, and P Richey, and M Kawai, and P Cras, and R N Kalaria, and P G Galloway, and J M Scardina, and B Cordell, and B D Greenberg
February 2022, Neuropathology and applied neurobiology,
G Perry, and S L Siedlak, and P Richey, and M Kawai, and P Cras, and R N Kalaria, and P G Galloway, and J M Scardina, and B Cordell, and B D Greenberg
January 1989, Virchows Archiv. B, Cell pathology including molecular pathology,
G Perry, and S L Siedlak, and P Richey, and M Kawai, and P Cras, and R N Kalaria, and P G Galloway, and J M Scardina, and B Cordell, and B D Greenberg
December 2003, Neuroscience letters,
G Perry, and S L Siedlak, and P Richey, and M Kawai, and P Cras, and R N Kalaria, and P G Galloway, and J M Scardina, and B Cordell, and B D Greenberg
January 1990, Lancet (London, England),
G Perry, and S L Siedlak, and P Richey, and M Kawai, and P Cras, and R N Kalaria, and P G Galloway, and J M Scardina, and B Cordell, and B D Greenberg
January 2007, Acta neuropathologica,
G Perry, and S L Siedlak, and P Richey, and M Kawai, and P Cras, and R N Kalaria, and P G Galloway, and J M Scardina, and B Cordell, and B D Greenberg
January 1985, Journal of submicroscopic cytology,
Copied contents to your clipboard!